Lead the Way in GPCR Drug Discovery

Chemical and Engineering News - United States
doi 10.1021/cen-v083n032.p040
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

American Chemical Society (ACS)

Related search

Biased Agonism: An Emerging Paradigm in GPCR Drug Discovery

Bioorganic and Medicinal Chemistry Letters
Organic ChemistryMolecular MedicineMolecular BiologyBiochemistryClinical BiochemistryPharmaceutical ScienceDrug Discovery
2016English

Computational Chemistry in Drug Lead Discovery and Design

International Journal of Quantum Chemistry
Condensed Matter PhysicsMolecular Physics,Theoretical ChemistryAtomicOpticsPhysical
2018English

A New Era for GPCR Research: Structures, Biology and Drug Discovery

Acta Pharmacologica Sinica
MedicinePharmacology
2012English

Discovery and Characterization of the Tuberculosis Drug Lead Ecumicin

Organic Letters
BiochemistryOrganic ChemistryTheoretical ChemistryPhysical
2014English

Seeking Ligand Bias: Assessing GPCR Coupling to Β-Arrestins for Drug Discovery

Drug Discovery Today: Technologies
BiotechnologyDrug DiscoveryMolecular Medicine
2010English

In Silico Strategies to Support Fragment-To-Lead Optimization in Drug Discovery

Frontiers in Chemistry
Chemistry
2020English

Nuclear Exodus: Herpesviruses Lead the Way

Annual Review of Virology
Virology
2016English

Drug Discovery

Journal of Antivirals & Antiretrovirals
2010English

Discovery of New GPCR Ligands to Illuminate New Biology

Nature Chemical Biology
Cell BiologyMolecular Biology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy